Join Pasithea for a virtual key opinion leader (KOL) event featuring Rebecca M. Brown, MD (University of Alabama at Birmingham) and Kavita Sarin, MD, PhD (Stanford Cancer Institute), who will join company management to discuss the unmet need and current treatment landscape for Neurofibromatosis Type 1 (NF1) cutaneous neurofibromas (cNF) and plexiform neurofibromas (PN).

The event will also provide an overview of Pasithea’s lead candidate, PAS-004, including Phase 1 solid tumor data presented at ESMO 2026, and summarize its commercial opportunity across both NF1 disease manifestations.

A Q&A session will follow the formal presentations.